We are live on ! Find out more
PMAM

Picton Mahoney Asset Management Portfolio holdings

AUM $13.5B
1-Year Est. Return 51.47%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+51.47%
3 Year Est. Return
+209.24%
5 Year Est. Return
+374.21%
10 Year Est. Return
+1,935.98%
AUM
$5.81B
AUM Growth
+$908M
Cap. Flow
+$1.11B
Cap. Flow %
19.15%
Top 10 Hldgs %
46.19%
Holding
1,073
New
222
Increased
220
Reduced
204
Closed
143

Sector Composition

Rank Sector Weight
1 Financials 12.92%
2 Technology 10.26%
3 Industrials 4.82%
4 Healthcare 4.53%
5 Consumer Discretionary 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONO icon
576
Sonos
SONO
$1.96B
$21K ﹤0.01%
+1,925
New +$25.3K
TSBK icon
577
Timberland Bancorp
TSBK
$361M
$21K ﹤0.01%
675
-299
-31% -$9.01K
FFNW
578
DELISTED
First Financial Northwest, Inc
FFNW
$21K ﹤0.01%
+923
New +$19.8K
BPMC
579
DELISTED
Blueprint Medicines
BPMC
$20K ﹤0.01%
217
+177
+443% +$17.3K
CIVB icon
580
Civista Bancshares
CIVB
$595M
$20K ﹤0.01%
1,033
-378
-27% -$7.73K
CWBC
581
Community West Bancshares
CWBC
$706M
$20K ﹤0.01%
+1,072
New +$20.1K
HYAC.WS
582
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
$20K ﹤0.01%
100,000
INBK icon
583
First Internet Bancorp
INBK
$256M
$20K ﹤0.01%
+728
New +$22.6K
ENTA icon
584
Enanta Pharmaceuticals
ENTA
$391M
$19K ﹤0.01%
+3,435
New +$21.2K
IYR icon
585
iShares US Real Estate ETF
IYR
$4.58B
$19K ﹤0.01%
200
-900
-82% -$85.6K
SPKLW
586
Spark I Acquisition Corp Warrant
SPKLW
$6.6M
$19K ﹤0.01%
125,000
SUPN icon
587
Supernus Pharmaceuticals
SUPN
$2.74B
$19K ﹤0.01%
594
+558
+1,550% +$19.8K
TCMD icon
588
Tactile Systems Technology
TCMD
$537M
$19K ﹤0.01%
1,424
+351
+33% +$5.52K
BIO icon
589
Bio-Rad Laboratories Class A
BIO
$9.66B
$18K ﹤0.01%
72
-26
-27% -$7.82K
BRKR icon
590
Bruker
BRKR
$8.83B
$18K ﹤0.01%
+433
New +$22.5K
EGHT icon
591
8x8 Inc
EGHT
$303M
$18K ﹤0.01%
8,873
-2,231
-20% -$5.75K
HWC icon
592
Hancock Whitney
HWC
$6.37B
$18K ﹤0.01%
334
-239
-42% -$13.4K
ZBRA icon
593
Zebra Technologies
ZBRA
$18B
$18K ﹤0.01%
65
-17
-21% -$5.81K
CNDT icon
594
Conduent
CNDT
$252M
$17K ﹤0.01%
6,390
-2,394
-27% -$8.75K
EDIT icon
595
Editas Medicine
EDIT
$432M
$17K ﹤0.01%
14,906
+1,821
+14% +$2.68K
KRBN icon
596
KraneShares Global Carbon Strategy ETF
KRBN
$132M
$17K ﹤0.01%
600
-600
-50% -$17.5K
NBN icon
597
Northeast Bank
NBN
$1.16B
$17K ﹤0.01%
189
-134
-41% -$13.1K
PGEN icon
598
Precigen
PGEN
$2.32B
$17K ﹤0.01%
+10,811
New +$17K
DYNCW
599
Dynamix Corp Warrant
DYNCW
$17K ﹤0.01%
+62,500
New +$17.6K
BLUE
600
DELISTED
bluebird bio
BLUE
$16K ﹤0.01%
+3,220
New +$19.4K

Similar funds

Picton Mahoney Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Picton Mahoney Asset Management held 1,073 positions worth $5.81B, up 19% from $4.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Picton Mahoney Asset Management deployed $1.11B of net new capital in Q1 2025, opening 222 new positions and adding to 220 existing holdings. Its largest new stake was Charles Schwab: 321,930 shares worth $25.2M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Applovin, an estimated $20.6M trimmed.

  • Picton Mahoney Asset Management's largest Q1 2025 buy was Charles Schwab: 321,930 shares worth $25.2M.
  • Picton Mahoney Asset Management added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $45.5M increase.
  • Picton Mahoney Asset Management's biggest Q1 2025 reduction was Applovin, cutting an estimated $20.6M.
  • Picton Mahoney Asset Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $53M.
  • Picton Mahoney Asset Management's ten largest holdings make up 46% of its $5.81B portfolio in Q1 2025.
  • Picton Mahoney Asset Management opened 222 new positions and closed 143 in Q1 2025.
  • Picton Mahoney Asset Management's portfolio value rose 19% quarter-over-quarter to $5.81B.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2025, filed 7 May 2025.